prof. dr. ir. F. (Floris) Foijer
In my lab, we are interested in the consequences of aneuploidy, an abnormal DNA content affecting 2 out of 3 cancers. By understanding how cancer cells make use of the advantages of aneuploidy and cope with the disadvantages of aneuploidy, we hope to get to therapies that can eradicate aneuploid cancers.
|Last modified:||06 October 2020 4.40 p.m.|